Insulin Resistance Following ADT for Prostate CA
NCT04658849
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
End of grant funding
Conditions
Insulin Resistance
Prostate Cancer
Interventions
DRUG:
Pioglitazone 30 Mg Oral Tablet
DRUG:
Pioglitazone placebo tablet
Sponsor
St. Louis University